A phase I study of cetuximab in combination with gemcitabine and radiation for locally advanced pancreatic cancer.

CONCLUSIONS: The combination of cetuximab, gemcitabine, and radiation resulted in significant toxicity. A recommended phase II dose could not be determined. PMID: 23077684 [PubMed]
Source: Gastrointestinal Cancer Research - Category: Cancer & Oncology Tags: Gastrointest Cancer Res Source Type: research